Key result
A new intracardiac microaxial pump for biventricular intracorporeal circulation during beating heart CABG surgery was safe, with no pump-related life-threatening or severe adverse events.
Why the study?
Does a new intracardiac microaxial pump improve hemodynamic stability and reduce procedure time compared to conventional cardiopulmonary bypass in patients undergoing CABG surgery?
RCT (n=80)
Randomized
Yes
Does a new intracardiac microaxial pump improve hemodynamic stability and reduce procedure time compared to conventional cardiopulmonary bypass in patients undergoing CABG surgery?
A new intracardiac microaxial pump for biventricular intracorporeal circulation during beating heart CABG appears safe and maintains hemodynamic stability during back wall vessel exposure.
Answers are grounded in this paper and cite their sources.
Supports safe use of intracardiac microaxial pump in beating-heart CABG; extends options beyond conventional bypass for further efficacy trials.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Autschbach et al. (2001) conducted an RCT in Coronary artery bypass grafting (CABG) surgery (n=80). Intracardiac microaxial pump vs. Conventional cardiopulmonary bypass setup was evaluated on Procedure time, mean arterial pressure, hemolysis, and adverse events. A new intracardiac microaxial pump for biventricular intracorporeal circulation during beating heart CABG surgery was safe, with no pump-related life-threatening or severe adverse events.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: